4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole>95.0%(GC)1g

6-Bromo-5-methylquinazolin-4(3H)-one, ��97.0%, 250mg

2-(3-Methoxyazetidin-1-yl)ethanamine, 98%, 250mg

2,2'-(4,5,6-Trifluorobenzene-1,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 100mg

5,5-BIS(BROMOMETHYL)-2-PHENYL-1,3-DIOXANE, 95.0%, 250mg

(R)-3-Methoxypyrrolidine hydrochloride, 95.0%, 1g

2-Methoxy-4-(4-(trifluoromethyl)piperidin-1-yl)aniline, 95+%, 1g

Lead(IV) oxide, min. 97%, pa, 100 g, plastic packaging.

(R)-1-(6-CHLOROPYRIDIN-3-YL)ETHANAMINE DIHYDROCHLORIDE, 95%, 100mg

tert-Butyldimethylchlorosilane, 98%, 250g

5-Carboxyfluorescein Diacetate>93.0%(HPLC)(T)200mg

4'-methyl-3-piperidinomethyl benzophenone, 97.0%, 1g

Sodium acetate, anhydrous, 99.0%, 500g